Merck (MRK) stock news

Merck (MRK) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-11-10 01:00:15 UTC#604467newreportednews

Doctors Without Borders urges wider use of Merck Ebola vaccine in DRC outbreak, Bloomberg reports

bloombergimportance 0.40trust 0.80Merck & Co., Inc. +0.30Doctors Without Borders +0.30Democratic Republic of the Congo -0.20

2026-11-09 23:12:05 UTC#604482newconfirmednews

Moderna reports positive Phase 3 data for intismeran cancer vaccine, showing 42% reduction in melanoma recurrence

Open sourceimportance 0.80trust 0.70Moderna, Inc. +0.90Merck & Co., Inc. +0.60intismeran +0.80+2 entities

2026-11-09 20:02:01 UTC#602779duplicateconfirmednews

Merck's efinopegdutide meets primary endpoint in Phase 2 MASH trial

seeking alphaimportance 0.30trust 0.70Merck & Co., Inc. +0.60efinopegdutide +0.60

2026-11-09 18:14:39 UTC#602326duplicateconfirmednews

Merck reports positive Phase 2b trial results for efinopegdutide in MASH patients with stage 2-3 fibrosis

reutersimportance 0.40trust 0.90Merck & Co., Inc. +0.60Efinopegdutide +0.60Metabolic dysfunction-associated steatohepatitis +0.50

2026-11-09 18:06:08 UTC#602267newconfirmednews

Merck reports positive Phase 2b results for efinopegdutide in MASH patients with stage 2-3 fibrosis at 52 weeks

first_squawkimportance 0.60trust 0.70Merck & Co., Inc. +0.60efinopegdutide +0.60Metabolic dysfunction-associated steatohepatitis +0.60

2026-11-08 15:34:47 UTC#596112newconfirmedanalysis

Merck & Co. (MRK) ranked 7th in list of healthcare stocks to buy following Democratic midterm election victory

yahooimportance 0.30trust 0.30Merck & Co., Inc. +0.30Donald Trump 0Democratic Party +0.30+2 entities

2026-11-07 02:31:00 UTC#593714newconfirmedanalysis

Rising Chinese Pharmaceutical Innovation Poses Long-Term Competitive Threat to Global Drugmakers, Barron's Reports

dow_jonesimportance 0.40trust 0.80Merck & Co., Inc. +0.20Sichuan-Kelun Pharmaceutical Co., Ltd. +0.40Akeso, Inc. +0.40+2 entities

2026-11-05 08:00:00 UTC#578533newconfirmednews

Merck Q3 2026 sales $18.09B, EPS $2.04; reports new product approvals and multiple acquisitions

tradingviewimportance 0.70trust 0.80Merck & Co., Inc. -0.20Lipfendra +0.30Idvynso +0.30+2 entities

2026-11-04 21:06:00 UTC#574992newconfirmednews

US markets rally as Dow gains 3% and S&P 500 rises 1.8% following midterm election results

yahooimportance 0.60trust 0.50Amgen Inc. +0.10Gilead Sciences, Inc. +0.10Vertex Pharmaceuticals Incorporated +0.10+2 entities

2026-11-04 01:30:00 UTC#567464newconfirmedpress release

Bio-Techne declares $0.08 quarterly dividend payable November 23, subject to Merck KGaA transaction status

pr_newswireimportance 0.30trust 1.00Bio-Techne Corporation +0.20Merck KGaA 0

2026-11-03 21:14:10 UTC#566097newconfirmednews

Merck receives US FDA emergency use authorization for canine screwworm treatment

reutersimportance 0.30trust 0.90Merck & Co., Inc. +0.40U.S. Food and Drug Administration +0.20

2026-11-03 11:45:00 UTC#562279newconfirmednews

Merck & Co. initiates ENHANCE-3 Phase 3 trial of OHTUVAYRE for COPD exacerbation prevention

tradingviewimportance 0.40trust 0.70Merck & Co., Inc. +0.30OHTUVAYRE +0.30ENHANCE-3 +0.20

2026-11-03 09:18:29 UTC#561312duplicateconfirmednews

Lonza to acquire five US manufacturing sites from Merck KGaA

reutersimportance 0.30trust 0.90Lonza Group AG +0.40Merck KGaA -0.20

2026-11-03 08:20:00 UTC#561038duplicateconfirmedanalysis

Stifel views Lonza's acquisition of Merck's US CDMO network as attractively valued at 300-400 million Swiss francs

dow_jonesimportance 0.30trust 0.80Lonza Group AG +0.30Merck KGaA -0.20Stifel Financial Corp. 0+1 entities

2026-11-03 07:45:52 UTC#560877duplicateconfirmednews

Merck KGaA divests U.S. CDMO operations to Lonza Group

seeking alphaimportance 0.30trust 0.70Merck KGaA -0.20Lonza Group AG +0.30

2026-11-03 06:49:56 UTC#560544duplicateconfirmednews

Merck KGaA confirms divestment of CDMO business to Lonza

reutersimportance 0.30trust 0.90Merck KGaA -0.20Lonza Group AG +0.30

2026-11-03 06:43:00 UTC#560527duplicateconfirmednews

Lonza Group to acquire five U.S. drug manufacturing sites from Merck KGaA

dow_jonesimportance 0.30trust 0.90Lonza Group AG +0.40Merck KGaA +0.20

2026-11-03 06:28:00 UTC#560395duplicateconfirmednews

Lonza Group to acquire five U.S. CDMO manufacturing sites from Merck KGaA

dow_jonesimportance 0.30trust 0.90Lonza Group AG +0.40Merck KGaA -0.20

2026-11-03 06:26:19 UTC#560413updateconfirmednews

Lonza details expansion of acquired Merck KGaA US CDMO sites, targeting CHF 250m sales by 2028

quartrimportance 0.50trust 0.70Merck KGaA +0.20

2026-11-03 06:23:43 UTC#560385newconfirmednews

Lonza to acquire Merck KGaA's US CDMO network for low- to mid-triple-digit millions CHF, closing mid-2027

reutersimportance 0.70trust 0.90Lonza Group AG +0.50Merck KGaA -0.30United States 0